naturalX Health Ventures is a €100 million venture capital fund focused on investments in consumer health companies. The firm aims to be the leading European investor in Consumer Health, specifically at the intersection of wellness and medicine. It is financially driven and backed by the Schwabe Group, a global leader in plant-based pharmaceuticals, providing a unique heritage in the natural health space. naturalX aims to bridge the gap between traditional natural health and digital health solutions, uniting established practices with innovative approaches. The firm's investment strategy centers around supporting companies with scientifically-backed products and solutions that demonstrate strong customer or patient engagement. They are flexible across stages but primarily focus on Series A and Series B investments, where product-market fit is evident. naturalX targets companies within the proactive health and mental health sectors, leveraging Schwabe Group's expertise in plant-based pharmaceuticals for mental health. They invest in digital mental health solutions and alternative approaches. naturalX makes direct investments into startups, with a preference for Series A rounds, and also invests as an LP in other funds. Their investment approach is flexible and focused on building the next generation of consumer health champions.
Preferred startup development maturity for initial funding deployment.
Proactive Health (prevention & longevity, sleep, nutrition & supplements, bio-hacking, genomics, wearables, digital therapeutics, at-home diagnostics, remote care), Mental Health, Consumer Health
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...